mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.22 |
6e-05 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
6e-05 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.21 |
0.0002 |